Clinical Trial Update: An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

View source ↗

Summary

An observational study evaluating the combination of erlotinib and gemcitabine in metastatic pancreatic cancer; the study has completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pancreatic Cancer | Status: COMPLETED | Results posted: 2018-07-23